An official website of the United States government
This list is for the codes only. Use this list to give to the IT programmers. The long version has additional explanations and notes for many of the codes.
These tables are also available in a printable version (PDF, 572 KB).
Comprehensive ICD-10 Casefinding "Must Collect" Code List for Reportable Tumors (Effective Date: 1/1/2011)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B21._ | Human Immunodeficiency virus [HIV] disease with malignant neoplasms |
| C00._ – C97._ | Malignant neoplasms |
| D00._ – D09._ | In-situ neoplasms |
| D18.0 | Hemangioma, any site |
| D18.1 | Lymphangioma, any site |
| D32._ – D33._ | Benign neoplasm of meninges (cerebral, spinal and unspecified), brain and other parts of central nervous systems |
| D35.2 – D35.4 | Benign neoplasm of pituitary gland, craniopharyngeal duct, pineal gland |
| D39.0 | Neoplasm of uncertain behavior uterus |
| D42._ – D43._ | Neoplasm of uncertain or unknown behavior of meninges, brain and central nervous system |
| D44.3 – D44.5 | Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
| D45._ – D46._ | Polycythemia vera, Refractory anemia |
| D47.1, D47.3, D47.7, D47.9 | Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue |
| D48.9 | Neoplasm of uncertain or unknown behavior, unspecified |
| D76.0 | Langerhans cell histiocytosis, not elsewhere classified |
NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.
Supplementary List: ICD-10 Code List to Screen For Cancer Cases Not Identified by Other Codes (Effective Date: 1/1/2011)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B20._, B22._, B23._, B24._ | Human immunodeficiency virus [HIV] disease |
| B99 | Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II and 2) |
| D10._ – D41._, D44._ | Benign neoplasms (except for D32, D33, D35.2 – D35.4) and neoplasms of uncertain or unknown behavior (except for D39.0, D42, D43, D44.3 – D44.5) |
| D47.0, D47.2 | Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue |
| D48._ | Neoplasms of uncertain or unknown behavior |
| D60._, D61._, D64._ | Aplastic anemias and other anemias (except for D61.0) |
| D70._ | Agranulocytosis |
| D72.1 | Eosinophilia |
| D75.0 | Familial erythrocytosis (familial polycythemia) |
| D75.8 | Other specified diseases of blood and blood forming organs |
| D76.1 – D76.3 | Certain diseases involving lymphoreticular tissue and reticulohistiocytic system |
| D80.0 – D80.1, D80.3 – D80.5 | Immunodeficiency with predominantly antibody defects |
| D81._ | Combined immunodeficiencies (except for D81.3, D81.5) |
| D82.0 | Wiskott-Aldrich syndrome |
| D83._ | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D84.1, D84.9 | Other immunodeficiencies |
| D89._ | Other disorders involving the immune mechanism, not elsewhere classified |
| E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone |
| E30.8 | Other disorders of puberty |
| E31.9 | Polyglandular dysfunction, unspecified |
| E34.0 – E34.1, E34.8 | Other endocrine disorders |
| E83.5 | Disorders of calcium metabolism |
| E88.0, E88.8 – E88.9 | Other metabolic disorders |
| G04.8 | Other encephalitis, myelitis, and encephalomyelitis |
| H55 | Nystagmus and other irregular eye movements |
| J90 | Pleural effusion, not elsewhere classified |
| K12.1 | Other forms of stomatitis |
| K31.7 | Polyp of stomach and duodenum |
| L30.4 | Erythrema intertrigo |
| L53.8 | Other specified erythematous conditions |
| L83 | Acanthosis nigricans |
| L88 | Pyoderma gangrenosum |
| M33.2 | Polymyositis |
| M33.9 | Dermatopolymyositis, unspecified |
| M35.9 | Systemic involvement of connective tissue, unspecified |
| M84.4 | Pathologic fracture, not elsewhere classified |
| O01._ | Hydatidiform mole |
| Q85.0 | Neurofibromatosis (nonmalignant) (9540/1) |
| Q90._ | Down's syndrome |
| R18 | Ascites |
| R52.9 | Pain, unspecified |
| R59._ | Enlarged lymph nodes |
| R85.6 | Abnormal findings in specimens from digestive organs and abdominal cavity, abnormal cytological findings |
| R87.6 | Abnormal findings in specimens from female genital organs, abnormal cytological findings. |
| T45.1 | Poisoning by antineoplastic and immunosuppressive drugs |
| T66 | Unspecified effects of radiation |
| T80.2, T80.8 | Complications following infusion, transfusion, and therapeutic injection |
| Y43.1 – Y43.3 | Adverse effects in therapeutic use, antineoplastic products or drugs |
| Y63.2 | Failure in dosage, overdose of radiation given during therapy |
| Y84.2 | Abnormal reaction, radiological procedure and radiotherapy |
^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007
